ABL1 is a gene located in band 9q34 coding for a protein that has a tyrosine kinase activity. Its main fusion partner is a DNA sequence called BCR (breakpoint cluster region) involved in the t(9;22)(q34;q11) present in more than 95% of patients with chronic myeloid leukemia and in some 20% of the adults with pre-B acute lymphoblastic leukemia (ALL). 1, 2 Few other ABL1 partners have been described. They are ETV6 rearranged in t(9;12)(q34;p13) rarely found in acute leukemia and myeloproliferative disorders, 3, 4 NUP214 fused to ABL1 on amplified episomes in T-cell ALL, 5 and EML1 rearranged in t(9;14)(q34;q32)-associated T-cell ALL. 6 All three fusion proteins act as constitutively activated tyrosine kinases. [4] [5] [6] Here we report the identification of a new putative ABL1 fusion partner, RCSD1, involved in a t(1;9)(q24;q34) translocation.
This 11-year-old boy was first seen in November 2003 at the Hematology Department of the CHU Brest. He was addressed for consolidation chemotherapy, including central nervous system prophylaxis (FRALLE 2000 protocol) of a pre-B ALL that had been diagnosed and treated 3 months earlier in a foreign country. He achieved a complete remission and remained under treatment until September 2005. At that time, hematological data were as follows: hemoglobin, 11.5 g/dl, white blood cells, 6.4 Â 10 9 /l with 47% blast cells and platelets at 104 Â 10 9 /l. The bone marrow aspirate showed hypercellularity with 92% blasts. Immunophenotyping showed the blast cells to be positive for CD10, CD22, CD24, CD19 (weak) and CD79a. A diagnosis of pre-B ALL in relapse was made. A second complete remission was achieved and the patient received a bone marrow transplantation in February 2006.
Cytogenetic analysis was performed on bone marrow and blood cells at the time of relapse. Briefly, the bone marrow and blood 24-h cultures were synchronized with FudR (10 À7 M) for 17 h followed by thymidine (10 À5 M) for 6 h before Colcemid exposure and standard harvesting. 7 The chromosomes were R-banded and the karyotype described according to the ISCN (1995). 8 A 46,Y,add(X)(p22),t(1;9)(q24;q34) [9] /46,XY[18] karyotype was found ( Figure 1 ).
Fluorescence in situ hybridization (FISH) using LSI bcr/abl dual extra-signal (ES) color and LSI TEL-AML1 ES dual-color probes (Abbott, Rungis, France) was performed as previously described. 9, 10 No fusion signals were observed with either probes. However, using LSI bcr/abl dual ES color probe, three red signals were seen, one on the normal chromosome 9, one on the der(9) and another on the der(1), signing the t(1;9) with involvement of the ABL1 gene.
To map the breakpoints of the t(1;9)(q24;q34), FISH was performed with appropriate sets of BAC clones. One BAC in band 9q34, RP11-83J21 containing the ABL1 gene and 16 on chromosome arm 1q were identified through the Human Genome Browser database of the Genome Bioinformatics Group at the University of California at Santa Cruz (http:// genome.ucsc.edu/) and the Ensembl genome data resources of the Sanger Institute Genome Database (http://ensembl.org/). Following bacterial growth and DNA extraction, the probe from chromosome 9 was labeled by nick translation in Spectrum Orange (Nick Translation Kit, Vysis, Rungis, France) and those from chromosome 1 in Spectrum Green (Prime-it Fluor Fluorescence Labeling Kit, Stratagene, Amsterdam, Netherlands). Split signals were observed for RP11-83J21 and RP11-232M22. Co-hybridization with these two probes show two yellow fusion signals (Figure 2 ). This breakpoint on chromosome 1 was further confirmed with four overlapping clones (RP11-928F1, RP11-138P14, RP11-652E14 and RP11-64D9).
Clone RP11-232M22 is located in band 1q24.2 and contains the RCSD1 gene, which codes a protein kinase substrate, CapZIP (CapZ-interacting protein), found in immune cells, splenocytes and muscle. 11 CapZIP interacts with the actincapping protein CapZ. It would function as a 'cap', stopping the fixation or loss of actin monomers at the extremities, influencing the size of actin filaments. It is possible that the interaction between CapZIP and CapZ affects the cell ability to remodel actin filament assembly.
CapZIP is phosphorylated when cells are exposed to various cellular stresses, which activate the kinase cascade. The interaction between CapZIP and CapZ would be lost when CapZIP is phosphorylated. So, RCSD1 would be involved in the remodeling of the actin cytoskeleton, which is an important step Figure 1 R-banded karyotype showing the t(1;9)(q24;q34) translocation.
Letters to the Editor in mitosis. The probable formation of the ABL1-RCSD1 fusion gene could result in an alteration of the cellular function by affecting the cytoskeleton regulation, which could be an important step in leukemogenesis. The vast majority of follicular lymphomas (FL) originate in lymph nodes and are characterized by a specific oncogenic event, the t(14;18)(q32;q21) translocation, juxtaposing the BCL2 gene on chromosome 18 with the immunoglobulin heavy chain locus on chromosome 14, leading to the overexpression of the antiapoptotic molecule BCL2. 1 On the other hand, there is a group of t(14;18)(q32;q21)-negative FLs, mostly found in skin or in other extranodal sites as well as in lymph nodes.
2 Follicular center cell lymphomas of the spleen rarely arise as primary splenic follicular lymphoma (PSFL), but involvement of the spleen is common in the context of a generalized lymphoma. To date, there are no data about the biological features of PSFL, due to the sporadic frequency of this pathologic entity. We report a PSFL case showing a novel fusion gene involving P2RY8 (G-protein coupled purinergic receptor P2Y8), and SOX5, one of the Sry (sex-determining region Y)-box (SOX) genes. The fusion was detected by fluorescence in situ hybridization (FISH) and reverse transcription (RT)-PCR. The P2RY8/SOX5 chimera resulted in the overexpression of SOX5 and the encoded protein, evaluated by real-time quantitative PCR (RQ-PCR) and immunohistochemistry, respectively.
In January 2004, a 58-year-old male patient presented with leukopenia (WBC count 3 Â 10 9 /l) and thrombocytopenia (PLT count 65 Â 10 9 /l). Physical examination showed splenomegaly (3 cm below the costal margin). Peripheral blood, bone marrow trephine and aspirate analysis did not reveal hematological disorders. Moreover, immunophenotypic and conventional cytogenetic analysis did not show clonal diseases. Virological search and total body computed tomography (CT) scans were negative. During the follow-up, the biological and clinical Figure 2 Dual-color FISH using RP11-83J21 (labeled in spectrum orange) and RP11-232M22 (labeled in spectrum green) showing two fusion genes. FISH, fluorescence in situ hybridization.
